Plain-English translation of NCT07722910 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand how diabetes damages blood vessels in your eyes by using a special, painless scanning technology called OCTA (optical coherence tomography angiography). This technology takes detailed pictures of blood flow in the iris—the colored part of your eye—to see if these images can help doctors identify and catch a serious eye complication called neovascular glaucoma earlier.
Diabetes can cause severe eye problems, including a dangerous condition where abnormal blood vessels grow in the eye and damage vision. Doctors need better ways to spot this condition early, so this study is testing whether measuring iris blood flow could be a simple, non-invasive tool to help identify patients at highest risk.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will share your basic health information and recent lab results from your medical records. You will then receive a painless, non-invasive scan of your iris using OCTA technology, which takes pictures of blood flow around the pupil from six different angles. The entire process is quick and comfortable, and you'll be placed in one of four groups depending on your diabetes status and eye health.
AI-generated summary from trial data · Aug 1, 2026 · Not medical advice
China